LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Jun 8, 2018
Financial News
Follow-on roundup: ImmunoGen, Mirati, Zymeworks, Viking, OptiNose
Read More
BioCentury
|
Jun 7, 2018
Financial News
Follow-on roundup: ImmunoGen, Mirati, Zymeworks, Viking, OptiNose
Read More
BioCentury
|
May 25, 2018
Clinical News
ImmunoGen reports updated Phase Ib/II data for ovarian cancer candidate
Read More
BioCentury
|
Mar 30, 2018
Clinical News
ImmunoGen reports Phase Ib/II data for mirvetuximab soravtansine plus Keytruda in ovarian cancer
Read More
BioCentury
|
May 26, 2017
Clinical News
ImmunoGen reports Phase Ib data for mirvetuximab soravtansine in ovarian cancer
Read More
BioCentury
|
Feb 3, 2017
Clinical News
Mirvetuximab soravtansine: Ph III FORWARD I started
Read More
BioCentury
|
Jul 11, 2016
Finance
Shedding red
Biotech winners, losers in 2Q16
Read More
BioCentury
|
May 9, 2016
Clinical News
Mirvetuximab soravtansine: Phase III amended
Read More
BioCentury
|
Apr 30, 2016
Clinical News
ImmunoGen falls after modifying ovarian cancer trial
Read More
BioCentury
|
Nov 16, 2015
Clinical News
Mirvetuximab soravtansine: Additional Phase I data
Read More
Items per page:
10
1 - 10 of 18
Help Center
Username
Request a Demo
Request Training
Ask a Question
Elevio by Dixa
Help